How much revenue does Tetra Bio-Pharma make?

Tetra Bio-Pharma reported 0 CAD in revenue for fiscal year 2021.

What companies are similar to Tetra Bio-Pharma?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Genex Pharmaceutical, Inc. (GENX), Kali, Inc. (KALY), Priority Aviation, Inc. (PJET), Baseline Productions, Inc. (BSSP).

Tetra Bio-Pharma Inc. (TBPMQ) Stock

About Tetra Bio-Pharma Inc.

Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of immunomodulator drugs. The company develops PLENITUDE to treat cancer-related pain in advanced cancer patients; and REBORN for the treatment of breakthrough cancer pain. It also develops novel prescription drugs and treatments to relieve symptoms associated with advanced cancer pain, chronic pain, Acute...

At a glance

Tetra Bio-Pharma reported revenue of 0 CAD for fiscal year 2021, and net income of -52.18 million CAD.

Figures from company filings; latest fiscal year ended November 30, 2021.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.